MacroGenics
Develops engineered antibody therapies for cancer through internal programs and collaborations.
$4.10
After-hours close−0.04 (−0.97%)
At close$4.14(+1.47%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.29 | — | — |
| Aug 2026 | −$0.08 | $0.31 | +498.2% |
| May 2026 | −$0.57 | −$0.58 | −1.8% |
| Mar 2026 | −$0.42 | −$0.22 | +47.6% |
| Nov 2025 | −$0.48 | $0.27 | +156.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.29 | — | — | $40.6M | — | — |
| Aug 13, 2026 | −$0.08 | $0.31 | +498.2% | $59.1M | $32.8M | −44.5% |
| May 14, 2026 | −$0.57 | −$0.58 | −1.8% | $15.2M | $20.8M | +36.3% |
| Mar 9, 2026 | −$0.42 | −$0.22 | +47.6% | $34.6M | $41.2M | +19.2% |
| Nov 12, 2025 | −$0.48 | $0.27 | +156.3% | $27.8M | $72.8M | +161.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Jul 29, 2021 | ||||||
| Apr 29, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Jul 30, 2020 | ||||||
| May 5, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Jul 31, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 7, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 3, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Nov 2, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 4, 2016 | ||||||
| Feb 29, 2016 | ||||||
| Nov 4, 2015 | ||||||
| Aug 5, 2015 | ||||||